CMS Administrator Mehmet Oz, MD, is calling on the nation’s largest pharmacy benefit managers to voluntarily abandon the current drug rebate model, or risk its elimination by the government, Bloomberg reported June 24. “There’s a possibility that we have a…
Pharmacy
Although the number of adverse health events has been climbing in Minnesota since 2015, hospitals decreased medication errors by 44% in the last year, according to the state’s health department. In 2024, Minnesota hospitals and ambulatory surgery centers reported 624…
From streamlining prescription refills through mobile apps to using SMS alerts for real-time medication updates, health systems are reshaping the digital pharmacy experience with patients at the center. Below are responses from three pharmacy leaders who were asked: How has…
In early 2020, as health systems across the U.S. were dealing with the COVID-19 pandemic, Danville, Pa.-based Geisinger’s leadership team was also rethinking the structure of its ambulatory pharmacy operations and distribution channels. The result was the formation of Geisinger…
Jacqueline Corrigan-Curay, MD, acting director of the FDA’s Center for Drug Evaluation and Research, will step down in July after more than eight years at the agency, Bloomberg Law reported June 23. In an internal email obtained by the publication,…
Advertisement
The FDA has granted accelerated approval to datopotamab deruxtecan (Datroway) for adults with locally advanced or metastatic non-small cell lung cancer that carries an EGFR mutation and has progressed. Datopotamab deruxtecan, the first TROP2-directed therapy approved for lung cancer in…
A small study found that a stem cell-derived treatment helped people with Type 1 diabetes produce their own insulin and, in most cases, enabled patients to discontinue use of external insulin altogether. The research, published June 20 in The New…
President Donald Trump has signed two executive orders aimed at reducing the cost of prescription drugs, but pharmaceutical benefit managers have been a small part of the legislation. Here’s what to know about the president’s approach to PBM policy so…
The FDA has approved Sanofi and Regeneron’s Dupixent as a treatment for adults with bullous pemphigoid, a rare chronic autoimmune skin condition that causes severe itching, painful blisters and open sores. Bullous pemphigoid primarily affects older adults. Current treatments often…
Here are 11 new shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists.